Search

  • HOME
  • Search
Original Article
651
Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, Ae Jin Jeong, Song-Hee Lee, Sang-Kyu Ye, Chan Soo Shin
J Bone Metab. 2022;29(2):93-101.   Published online May 31, 2022
View: 280   Download: 23
608
Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year
Tarun Kadaru, Amal Shibli-Rahhal
J Bone Metab. 2021;28(1):51-58.   Published online February 28, 2021
View: 2694   Download: 140  Citations: 3
Could Prior Oral-bisphosphonate Administration Reduce the Acute Phase Reaction of Zoledronate?
서성화조환성천상호정혜미박일형*
J Bone Metab. 2011;18(1):49-54.
View: 595   Download: 7
Predictors of Acute Phase Response after Intravenous Zoledronic Acid in Patients with Osteoporotic Fracture
Young-Kyun Lee Ji Hoon Baek Yong-Chan Ha* Kyung-Hoi Koo
J Bone Metab. 2010;17(2):103-107.
View: 545   Download: 3

Journal of Bone
Metabolism

Print ISSN: 2287-6375
Online ISSN: 2287-7029



Editorial Office
#1001, Hyundai Kirim Officetel, 42 Seocho-daero 78-gil, Seocho-gu, Seoul 06626, Korea
Tel: +82-2-3473-2231    Fax: +82-70-4156-2230    E-mail: editors.jbm@gmail.com                

Copyright © 2022 by The Korean Society for Bone and Mineral Research.

Developed in M2PI

Close layer
prev next